Concepedia

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma

Han‐Shui Hsu, T.T. Chen, Chein‐Hui Hung, Chiao‐Kai Wen, Rou‐Kai Lin, Hui‐Chen Lee, Yi‐Ching Wang

Cancer · 2007 · 145 citations · 17 references

DOIFull text

Open access

Abstract

The current results indicated that multiple epigenetic markers in the plasma, especially the p16 and RASSF1A genes, can be used for lung cancer detection. This methylation marker panel should improve the detection of cancer or the risk assessment for lung cancer in combination with conventional diagnostic tools.

References

17

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

Adrian Merlo, James G. Herman, Li Mao et al. · Nature Medicine · 1995 · 2K citations

, , +14

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Manel Esteller, Montse Sánchez‐Céspedes, Rafael Rosell et al. · PubMed · 1999 · 928 citations

, , +21

Prognosis and survival in resected lung carcinoma based on the new international staging system

Tsuguo Naruke, Tomoyuki Goya, Ryosuke Tsuchiya et al. · Journal of Thoracic and Cardiovascular Surgery · 1988 · 691 citations

, , +7

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

Henning Usadel, Jan Brabender, K. D. Danenberg et al. · PubMed · 2002 · 303 citations

, , +18

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

Kiyomi O. Toyooka, Shinichi Toyooka, Arvind K. Virmani et al. · PubMed · 2001 · 243 citations

, , +19